Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice

Journal of Nutritional Biochemistry

Volumn 26, Issue 3, 2015, Pages 219-226

  Kanda, Yukiko ^a   Hashiramoto, Mitsuru ^b   Shimoda, Masashi ^a   Hamamoto, Sumiko ^a   Tawaramoto, Kazuhito ^a   Kimura, Tomohiko ^a   Hirukawa, Hidenori ^a   Nakashima, Koji ^a   Kaku, Kohei ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b YODOGAWA CHRISTIAN HOSPITAL   (Japan)

Author keywords

B cell dysfunction; Cell apoptosis; Cell proliferation; Dietary restriction; Oxidative stress

Indexed keywords

CYCLIN D; GLUCOSE; INSULIN; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR; DEOXYRIBONUCLEASE; DFFB PROTEIN, MOUSE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL KINETICS; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; FOOD INTAKE; GENE EXPRESSION PROFILING; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; REGULATORY MECHANISM; ANIMAL; BLOOD; CALORIC RESTRICTION; CELL SIZE; CROSS BREEDING; DIET THERAPY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INSULIN RESISTANCE; KINETICS; METABOLISM; MUTANT MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; SECRETION (PROCESS); STATISTICAL ANALYSIS;

MUS;

ANIMALS; APOPTOSIS; CALORIC RESTRICTION; CELL PROLIFERATION; CELL SIZE; CROSSES, GENETIC; CYCLIN D; DEOXYRIBONUCLEASES; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; KINETICS; MALE; MATCHED-PAIR ANALYSIS; MICE, MUTANT STRAINS; OXIDATIVE STRESS;

EID: 84927607344     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.10.007     Document Type: Article

References (36)

1. Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?. Diabetes 1994, 43:735-740.
2. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15:318-368.
3. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
4. Kloppel G., Lohr M., Habich K., Oberholzer M., Heitz P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985, 4:110-125.
5. Buchanan T.A., Xiang A.H., Peters R.K., Kjos S.L., Marroquin A., Goico J., et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002, 51:2796-2803.
6. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 1998, 95:2498-2502.
7. Wang J., Luben R., Khaw K.T., Bingham S., Wareham N.J., Forouhi N.G. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of Cancer (EPIC)-Norfolk Study. Diabetes Care 2008, 31:2120-2125.
8. Masoro E.J. Dietary restriction and aging. J Am Geriatr Soc 1993, 41:994-999.
9. Bantle J.P., Wylie-Rosett J., Albright A.L., Apovian C.M., Clark N.G., Franz M.J., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl. 1):S61-S78.
10. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
11. Wing R.R. Behavioral treatment of obesity. Its application to type II diabetes. Diabetes Care 1993, 16:193-199.
12. Wing R.R., Marquez B. Behavioral aspects of weight loss in type 2 diabetes. Curr Diab Rep 2008, 8:126-131.
13. Masoro E.J., McCarter R.J., Katz M.S., McMahan C.A. Dietary restriction alters characteristics of glucose fuel use. J Gerontol 1992, 47:B202-B208.
14. Cartee G.D., Kietzke E.W., Briggs-Tung C. Adaptation of muscle glucose transport with caloric restriction in adult, middle-aged, and old rats. Am J Physiol 1994, 266:R1443-R1447.
15. Craig B.W., Garthwaite S.M., Holloszy J.O. Adipocyte insulin resistance: effects of aging, obesity, exercise, and food restriction. J Appl Physiol 1987, 62:95-100.
16. Ohneda M., Inman L.R., Unger R.H. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 1995, 38:173-179.
17. Fontana L., Villareal D.T., Weiss E.P., Racette S.B., Steger-May K., Klein S., et al. Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metab 2007, 293:E197-E202.
18. Kitamura T., Kido Y., Nef S., Merenmies J., Parada L.F., Accili D. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 2001, 21:5624-5630.
19. Shao J., Iwashita N., Ikeda F., Ogihara T., Uchida T., Shimizu T., et al. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun 2006, 344:1224-1233.
20. Leibiger I.B., Berggren P.O. Sirt1: a metabolic master switch that modulates lifespan. Nat Med 2006, 12:34-36. [discussion 6].
21. Holman R.R. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 1998, (40 Suppl.):S21-S25.
22. Maedler K., Sergeev P., Ehses J.A., Mathe Z., Bosco D., Berney T., et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci U S A 2004, 101:8138-8143.
23. Soeller W.C., Janson J., Hart S.E., Parker J.C., Carty M.D., Stevenson R.W., et al. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 1998, 47:743-750.
24. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279:42351-42354.
25. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., et al. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 1999, 48:2398-2406.
26. Bates H.E., Sirek A., Kiraly M.A., Yue J.T., Riddell M.C., Matthews S.G., et al. Adaptation to intermittent stress promotes maintenance of beta-cell compensation: comparison with food restriction. Am J Physiol Endocrinol Metab 2008, 295:E947-E958.
27. Ishii Y., Ohta T., Sasase T., Morinag H., Miyajima K., Kakutani M. Effects of food restriction on pancreatic islets in Spontaneously Diabetic Torii fatty rats. J Vet Med Sci 2011, 73:169-175.
28. Kawasaki F., Matsuda M., Kanda Y., Inoue H., Kaku K. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am J Physiol Endocrinol Metab 2005, 288:E510-E518.
29. Gastaldelli A., Ferrannini E., Miyazaki Y., Matsuda M., Mari A., DeFronzo R.A. Thiazolidinediones improve beta-cell function in type 2 diabetic patients. Am J Physiol Endocrinol Metab 2007, 292:E871-E883.
30. Kanda Y., Shimoda M., Hamamoto S., Tawaramoto K., Kawasaki F., Hashiramoto M., et al. Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist. Am J Physiol Endocrinol Metab 2010, 298:E278-E286.
31. Hui H., Nourparvar A., Zhao X., Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 2003, 144:1444-1455.
32. Farilla L., Hui H., Bertolotto C., Kang E., Bulotta A., Di Mario U., et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 2002, 143:4397-4408.
33. Shimoda M., Kanda Y., Hamamoto S., Tawaramoto K., Hashiramoto M., Matsuki M., et al. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia 2011, 54:1098-1108.
34. Kanda Y., Shimoda M., Tawaramoto K., Hamamoto S., Tatsumi F., Kawasaki F., et al. Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote. Endocr J 2009, 56:997-1008.
35. Deng X., Cheng J., Zhang Y., Li N., Chen L. Effects of caloric restriction on SIRT1 expression and apoptosis of islet beta cells in type 2 diabetic rats. Acta Diabetol 2010, 47(Suppl 1):177-185.
36. Qiu X., Brown K., Hirschey M.D., Verdin E., Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010, 12:662-667.